search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Natural Products


A modern approach


to herbal healing mining plant genomes


Plants are stationary soldiers. Rooted to one spot, they are not able to chase nutrients or flee from herbivores and pathogens. So in addition to the basic metabolites they synthesise for their survival, they produce a diverse array of organic compounds through specialised biochemical pathways to counterattack threats. Some of these compounds have been found to combat human threats as well, and herbalists have been scouring these palettes of secondary metabolites for their health-promoting properties for centuries.


By Michelle Vierra


M


odern medicine also incorporates plant compounds. Around 80% of the world’s population already relies on


ethnobotanical remedies and plant drugs, such as the antineoplastic Taxol,


the antimalarial


artemisinin, the analgesic codeine, the antidiabetic allicin, and the cardiac depressant quinidine. The high cost of new drugs, unpalatable side-effects and microbial resistance are driving a constant and renewed public interest on alternative and comple- mentary medicine. Yet only a small fraction of the vast diversity of


plant metabolism has been explored. This is quickly changing, as synthetic biologists


set out to mine the quarry of alkaloids, terpenoids and phenolic plant compounds in order to manu- facture new natural products and molecular ‘pharmers’ try to identify ways to use the plants themselves as biopharmaceutical factories. The increased affordability and sophistication of genetic sequencing technology is making all of this


52


possible. But is it being used to its full potential? How can the technology be best utilised in drug discovery and development? It is no longer enough to simply sequence bits of


a genome. In order to understand the full metabol- ic potential of plants, comprehensive genomic information must be combined with transcriptom- ic, proteomic and metabolomic data. We need to be able to answer questions such as: How are the genes coded? Where are they clustered? Clustered genes in Arabidopsis, for example, are enriched in phenylpropanoid and terpenoid metabolism. Gene duplication, such as whole-genome duplications (WGDs) and local (tandem) duplication (LDs), can also play an important role in specialised metabolism, including the expression of flavonoid related genes. Fortunately, sequencing technology has evolved


to equip researchers with the tools to tackle nearly all of these questions. Single Molecule, Real-Time (SMRT) Sequencing,


Drug Discovery World Spring 2019


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64